Diagnostic method for alzheimer's disease based on...

Details Diagnostic method for alzheimer's disease based on... Diagnostic method for alzheimer's disease based on...

2007-11-13

2007-11-13

Wallenhorst, Maureen M. (Department: 1743)

Chemistry: analytical and immunological testing

Biological cellular material tested

C436S086000, C536S026400, C514S052000

Reexamination Certificate

active

10332041

ABSTRACT:
The invention provides a diagnostic or prognostic assay method for Alzheimer's Disease by assaying a body fluid sample or a test sample derived therefrom for holo-trancobalamin II.

REFERENCES:
patent: 4273757 (1981-06-01), Selhub et al.
patent: 4680273 (1987-07-01), Herbert
patent: 6417006 (2002-07-01), Sundrehagen
patent: WO 00/17659 (2000-03-01), None
Johnston et al. Journal of the American Geriatrics Society, vol. 45 (6), Jun. 1997, pp. 779-780.
Clarke Robert et al: “Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.” Archives of Neurology, vol. 55, No. 11, Nov. 1998, pp. 1449-1455.
Kristensen Marianne O et al: “Serum cobalamin and methymalonic acid in Alzheimer dementia.” ACTA Neurologica Acandinavica, vol. 87, No. 6, 1993, pp. 475-481.
Basun Hans et al: “Cobalamin levels are not reduced in Alzheimer's disease: Results from a population-based study.” Journal of the American Geriatrics Society, vol. 42, No. 2, 1994, pp. 132-136.

Affiliated with

Also associated with

Rating

Diagnostic method for alzheimer's disease based on... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic method for alzheimer's disease based on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method for alzheimer's disease based on... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3841367